TGFB1 and vascular malformation: This change in our understanding of the principal mechanisms regulating endothelial responses has wide implications for therapy, as Nrp1 inhibition becomes a highly attractive target to curb angiogenesis, or to modulate Tgf-β/Bmp responses in vascular malformations.